Cao Dongyan, Yang Jiaxin, Xiang Yang, Wu Ming, Pan Lingya, Huang Huifang, Lang Jinghe, Shen Keng
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China. Email:
Zhonghua Fu Chan Ke Za Zhi. 2014 Apr;49(4):249-53.
To evaluate the prognosis and fertility outcomes of patients with early stage of cervical cancer treated by vaginal radical trachelectomy (VRT) in combination with laparoscopic pelvic lymphadenectomy.
The surgical data, disease recurrences and fertility outcomes were analyzed retrospectively for 51 patients who received VRT in Peking Union Medical College Hospital from Dec. 2003 to Nov. 2013.
Forty-eight patients succeeded in preserving fertility. The median age was 29 years. International Federation of Gynecology and Obstetrics (FIGO) stage: 5 cases Ia1 with lymph vascular space invasion (LVSI), 4 cases Ia2 and 39 cases in stage Ib1. Tumor size: 20 cases with no visible lesion, 20 cases with tumor size ≤ 2 cm, 8 cases with tumor size > 2 cm. Histological type: 42 cases with squamous carcinoma, 6 cases with adenocarcinoma or adeno-squamous carcinoma. The mean excised cervical length and parametrial width was (2.6 ± 0.6) cm and (1.9 ± 0.5) cm, respectively. Six recurrences (12%) were observed after following up for a mean duration of (35 ± 21) months. The recurrent rate in patients with tumor size > 2 cm was 3/8, which was significantly higher than that of the patients with tumor size ≤ 2 cm (8%, 3/40;P < 0.01). Of the 35 patients who desired to conceive after the surgery, 13 women had 17 pregnancies and the pregnant rate was 37% (13/35). Nine women obtained 10 healthy live birth babies. The fertility rate was 26% (9/35).
VRT in combination with laparoscopic pelvic lymphadenectomy could preserve the fertility of patients with early stage of cervical cancer with acceptable oncologic and fertility outcomes. Tumor size ≤ 2 cm should be emphasized as the indication of VRT in considering of the higher recurrent rate in patients with tumor size > 2 cm.
评估经阴道根治性宫颈切除术(VRT)联合腹腔镜盆腔淋巴结清扫术治疗的早期宫颈癌患者的预后及生育结局。
回顾性分析2003年12月至2013年11月在北京协和医院接受VRT治疗的51例患者的手术资料、疾病复发情况及生育结局。
48例患者成功保留生育功能。中位年龄为29岁。国际妇产科联盟(FIGO)分期:5例Ia1期伴淋巴血管间隙浸润(LVSI),4例Ia2期,39例Ib1期。肿瘤大小:20例未见明显病灶,20例肿瘤大小≤2 cm,8例肿瘤大小>2 cm。组织学类型:42例为鳞状细胞癌,6例为腺癌或腺鳞癌。切除宫颈的平均长度和宫旁宽度分别为(2.6±0.6)cm和(1.9±0.5)cm。平均随访(35±21)个月后观察到6例复发(12%)。肿瘤大小>2 cm的患者复发率为3/8,显著高于肿瘤大小≤2 cm的患者(8%,3/40;P<0.01)。35例术后希望怀孕的患者中,13例女性有17次妊娠,妊娠率为37%(13/35)。9例女性分娩10例健康活婴。生育率为26%(9/35)。
VRT联合腹腔镜盆腔淋巴结清扫术可保留早期宫颈癌患者的生育功能,肿瘤学及生育结局均可接受。考虑到肿瘤大小>2 cm的患者复发率较高,应强调肿瘤大小≤2 cm作为VRT的指征。